Association of increased oncostatin M with adverse left ventricular remodeling in patients with myocardial infarction

Autor: Gusakova Anna M., Suslova Tatiana E., Kercheva Maria A., Kologrivova Irina V., Ryabova Tamara R., Ryabov Vyacheslav V.

Publikováno v: Journal of Medical Biochemistry, Vol 41, Iss 4, Pp 441-449 (2022)

Background: The study of laboratory biomarkers that reflect the development of adverse cardiovascular events in the postinfarction period is of current relevance. The aim of the present study was evaluation of oncostatin M (OSM) concentration changes

Externí odkaz: https://doaj.org/article/98f71c2ce42d412397e450fa0367afbf

Potential and place of efferent therapy in patients with myocardial infarction complicated by cardiogenic shock

Autor: M. A. Kercheva, O. O. Panteleev, V. V. Ryabov

Publikováno v: Российский кардиологический журнал, Vol 29, Iss 7 (2024)

Myocardial infarction complicated by cardiogenic shock (MI CS) is the terminal stage of the cardiovascular disease continuum, leading to the death of every second patient in its severe course. Over the past decades, there are no improvement in inhosp

Externí odkaz: https://doaj.org/article/3991b0599b5e46999d9d9fb8c7e38dff

Analysis of data from the Russian AURA registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease)

Autor: M. M. Batyushin, M. A. Trubnikova, G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, D. S. Polyakov, S. Sh. Akhmedkhanov, I. G. Bakulin, I. A. Bodrievskaya, I. A. Viktorova, N. G. Vinogradova, A. S. Galyavich, N. P. Garganeeva, N. Yu. Grigorieva, S. B. Erofeeva, M. A. Kercheva, S. G. Kechedzhieva, N. A. Koryagina, S. V. Malchikova, V. A. Nevzorova, S. V. Nedogoda, M. M. Petrova, V. A. Pogrebetskaya, A. P. Rebrov, O. A. Rubanenko, E. A. Safianik, V. V. Skibitsky, E. A. Smirnova, E. A. Starovoitova, R. F. Khamitov, A. I. Chesnikova, T. M. Shabatina, I. I. Shaposhnik, A. R. Vaisberg, A. V. Aparkina, I. N. Barykina, T. I. Batluk, R. A. Bashkinov, A. T. Beybalayeva, Y. A. Belenikina, O. A. Bilevich, Zh. V. Bondareva, A. Yu. Vaskin, T. V. Vlasova, E. V. Galko, T. U. Garifullin, E. D. Gordeychuk, E. V. Grigorieva, I. V. Gubareva, L. K. Danilova, A. I. Dolgushina, E. M. Durygina, D. S. Evdokimov, N. V. Zhdankina, E. I. Zheleznyak, D. S. Zueva, D. S. Ivanova, E. Yu. Ivanchenko, M. V. Kazakovtseva, A. A. Kaznina, N. A. Karoli, D. S. Kaskaeva, Z. F. Kim, M. V. Kozlova, Y. I. Kudrinskaya, A. S. Kuznetsova, E. Yu. Levchenko, I. A. Lukonin, V. O. Lutova, N. A. Magdeeva, E. V. Makarova, N. E. Makarova, M. M. Mamontova, E. S. Melnikov, A. F. Molostvova, T. D. Naborshchikova, I. N. Nikitina, D. P. Novikova, M. V. Novikova, V. I. Pakusina, K. G. Pereverzeva, I. S. Pleshakov, Yu. G. Pokramovich, O. V. Ponomareva, E. A. Popova, N. A. Popova, E. S. Potapova, E. D. Resnyanskaya, M. Yu. Rozhkova, A. O. Rubanenko, M. D. Rudoy, A. S. Salasyuk, L. M. Salimova, V. I. Samokhina, N. Sh. Sanginova, F. I. Sattarova, A. Kh. Safina, D. P. Sirotenko, N. S. Skarzhinskaya, A. V. Skibitsky, E. I. Suchkova, L. E. Tepnadze, A. V. Fendrikova, T. E. Filatova, O. V. Filyushin, O. Yu. Chizhova, T. I. Chudinovskikh, S. S. Yakushin, E. M. Yashina

Publikováno v: Российский кардиологический журнал, Vol 29, Iss 7 (2024)

Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of mark

Externí odkaz: https://doaj.org/article/e6737166623e4811afc3782016a90baa

Somatostatin Receptor Type 2 as a Potential Marker of Local Myocardial Inflammation in Myocardial Infarction: Morphologic Data on Distribution in Infarcted and Normal Human Myocardium

Autor: Vyacheslav V. Ryabov, Andrey A. Trusov, Maria A. Kercheva, Aleksandra E. Gombozhapova, Julia N. Ilyushenkova, Ivan V. Stepanov, Mikhail V. Fadeev, Anna G. Syrkina, Svetlana I. Sazonova

Publikováno v: Biomedicines, Vol 12, Iss 10, p 2178 (2024)

Nuclear imaging modalities can detect somatostatin receptor type 2 (SSTR2) in vivo as a potential marker of local post-MI inflammation. SSTR2+ macrophages are thought to be the main substrate for SSTR-targeted radioimaging. However, the distribution

Externí odkaz: https://doaj.org/article/099d8b193e1f4727afabbfd1aac4592e

Oral anticoagulants versus vitamin K antagonists in the treatment of non-valvular atrial fibrillation in patients with stage 4-5 chronic kidney disease

Autor: E. G. Skorodumova, O. A. Rubanenko, A. O. Rubanenko, S. T. Enginoev, M. A. Kercheva, E. L. Zaslavskaya, E. V. Efremova, E. Yu. Gubareva, I. N. Lyapina, R. M. Velieva, E. A. Skorodumova, A. V. Siverina

Publikováno v: Российский кардиологический журнал, Vol 29, Iss 1S (2024)

Aim. To compare the effectiveness and safety of direct oral anticoagulants (DOACs) with a vitamin K antagonist (VKA) in patients with atrial fibrillation (AF) and stage 4 and 5 chronic kidney disease (CKD).Material and methods. We searched in the Pub

Externí odkaz: https://doaj.org/article/31b7b020b21d4e9c9d9bf98476330d73